Fabrice Carrat to Polyethylene Glycols
This is a "connection" page, showing publications Fabrice Carrat has written about Polyethylene Glycols.
Connection Strength
0.165
-
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. Lancet Gastroenterol Hepatol. 2017 03; 2(3):177-188.
Score: 0.117
-
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial). Patient. 2017 10; 10(5):605-614.
Score: 0.031
-
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02. Antivir Ther. 2009; 14(2):211-9.
Score: 0.017